Thermosensitive in situ hydrogels of rivastigmine-loaded lipid-based nanosystems for nose-to-brain delivery: Characterisation, biocompatibility, and drug deposition …
S Cunha, M Swedrowska, Y Bellahnid, Z Xu… - International Journal of …, 2022 - Elsevier
Acetylcholinesterase inhibitors are the most used drugs to manage Alzheimer's disease,
although they show low bioavailability in the brain. In this sense, nasal administration has …
although they show low bioavailability in the brain. In this sense, nasal administration has …
Thermosensitive in situ hydrogels of rivastigmine-loaded lipid-based nanosystems for nose-to-brain delivery: characterisation, biocompatibility, and drug deposition …
S Cunha, M Swedrowska… - International …, 2022 - pubmed.ncbi.nlm.nih.gov
Acetylcholinesterase inhibitors are the most used drugs to manage Alzheimer's disease,
although they show low bioavailability in the brain. In this sense, nasal administration has …
although they show low bioavailability in the brain. In this sense, nasal administration has …
Thermosensitive in situ hydrogels of rivastigmine-loaded lipid-based nanosystems for nose-to-brain delivery: characterisation, biocompatibility, and drug deposition …
S Cunha, M Swedrowska, Y Bellahnid, Z Xu… - International Journal …, 2022 - europepmc.org
Acetylcholinesterase inhibitors are the most used drugs to manage Alzheimer's disease,
although they show low bioavailability in the brain. In this sense, nasal administration has …
although they show low bioavailability in the brain. In this sense, nasal administration has …